Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0IP1 stock hub

LON/0IP1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0IP1is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

170.9M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0IP1

In the news

Latest news · LON/0IP1

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E10.8

P25 12.9P50 16.9P75 23.5

Trailing P/E6.6

P25 15.9P50 22.9P75 35.8

ROE11.6

P25 -54.2P50 2.1P75 13.7

ROIC8.6

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0IP1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

222

Groups with data

Currency

EUR

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	3,641
Employees Change	260%
Employees Change Percent	7.7
Enterprise value	EUR 428.7M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	FR0000035370
Last refreshed	2026-05-10
Market cap	EUR 170.9M
Price	EUR 26.55
Price currency	EUR
Rev Per Employee	122,305.43x
Sector	Healthcare
Sic	7350
Symbol	lon/0IP1
Website	https://www.bastideleconfortmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	15.04%
EV Earnings	16.67x
EV/EBIT	10.38x
EV/EBITDA	4.66x
EV/FCF	8.86x
EV/Sales	0.97x
FCF yield	28.3%
Forward P/E	10.84x
P/B ratio	1.91x
P/E ratio	6.65x
P/S ratio	0.38x
PE Ratio10 Y	76.37x
PE Ratio3 Y	187.14x
PE Ratio5 Y	134.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.36%
EBITDA Margin	16.96%
FCF margin	10.86%
Gross margin	67.39%
Gross Profit	EUR 300.1M
Gross Profit Growth	3.3%
Gross Profit Growth Q	6.67%
Gross Profit Growth3 Y	3.68%
Gross Profit Growth5 Y	0.61%
Net Income	EUR 25.7M
Net Income Growth	1,652.26%
Net Income Growth Q	4,914.26%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Net Income Growth5 Y	19.59%
Pretax Margin	2.81%
Profit Margin	5.77%
Profit Per Employee	EUR 7,062
Profitable Years	1
ROA	4.75
Roa5y	4.11
ROCE	11.58
ROE	11.56
Roe5y	13.45
ROIC	8.64
Roic5y	5.53

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.26%
Cagr1y	-2.93%
Cagr3y	-1.99%
Cagr5y	-9.99%
Div CAGR10	5.99%
Div CAGR3	-1%
Div CAGR5	0.71%
EPS Growth	1,576.9
EPS Growth Q	4,611.9
EPS Growth Quarters	1
EPS Growth Years	1
EPS Growth5 Y	18.87
FCF Growth	62.24%
FCF Growth Q	76.03%
FCF Growth3 Y	31.37%
FCF Growth5 Y	1.28%
OCF Growth	31.7%
OCF Growth Q	25.19%
OCF Growth10 Y	9.15%
OCF Growth3 Y	15.39%
OCF Growth5 Y	1.45%
Revenue Growth	16.56x
Revenue Growth Q	8x
Revenue Growth Years	0x
Revenue Growth3 Y	3.39x
Revenue Growth5 Y	0.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.81
Assets	EUR 506.4M
Cash	EUR 22.2M
Current Assets	EUR 167.9M
Current Liabilities	EUR 145.3M
Debt	EUR 282.8M
Debt EBITDA	EUR 3.04
Debt Equity	EUR 3.16
Debt FCF	EUR 5.84
Equity	EUR 89.4M
Interest Coverage	1.75
Liabilities	EUR 417.1M
Long Term Assets	EUR 338.5M
Long Term Liabilities	EUR 271.7M
Net Cash	EUR -260.5M
Net Cash By Market Cap	EUR -152
Net Debt EBITDA	EUR 3.45
Net Debt Equity	EUR 2.92
Net Debt FCF	EUR 5.39
Tangible Book Value	EUR -78.3M
Tangible Book Value Per Share	EUR -10.57
WACC	7.26

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.16
Inventory Turnover	3.95
Net Working Capital	EUR 19.4M
Quick ratio	0.9
Working Capital	EUR 22.8M
Working Capital Turnover	EUR 14.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.95%
Dividend per share	EUR 0
Last Dividend	EUR 0.23

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	51.76%
1Y total return	-2.93%
200-day SMA	26.21
3Y total return	-5.85%
50-day SMA	24.55
50-day SMA vs 200-day SMA	50under200
5Y total return	-40.93%
All Time High	59.19
All Time High Change	-55.15%
All Time High Date	2018-01-09
All Time Low	13.8
All Time Low Change	92.39%
All Time Low Date	2024-04-02
ATR	0.49
Beta	0.89
Ch YTD	9.26
High	26.55
High52	33.3
High52 Date	2025-07-11
High52ch	-20.27%
Low	26.55
Low52	22.3
Low52 Date	2026-02-09
Low52ch	19.06%
Ma50ch	8.13%
Price vs 200-day SMA	1.31%
RSI	63.02
RSI Monthly	51.87
RSI Weekly	54.97
Sharpe ratio	0.33x
Sortino ratio	0.67
Total Return	-2.95%
Tr YTD	9.26
Tr1m	11.32%
Tr1w	6.63%
Tr3m	18.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 41.7M
Operating Income Growth	5.71
Operating Income Growth Q	10.89
Operating Income Growth3 Y	7.44
Operating Income Growth5 Y	2.21
Operating margin	9.36

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,394,508%
Net Borrowing	-89,114,699.4
Shares Insiders	1.62%
Shares Institutions	7.07%
Shares Qo Q	0.11%
Shares Yo Y	2.95%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 48.4M
Average Volume	131.85x
Bv Per Share	12.09
CAPEX	EUR -50.7M
Ch10y	44.53
Ch1m	11.32
Ch1w	6.63
Ch1y	-2.93
Ch3m	18.26
Ch3y	-5.85
Ch5y	-41.26
Ch6m	10.63
Change	-0.93%
Change From Open	0
Close	26.8
Days Gap	-0.93
Depreciation Amortization	33,559,769.4
Dollar Volume	23,895
Earnings Date	2026-10-21
EBIT	EUR 41.7M
EBITDA	EUR 75.5M
EPS	EUR 3.15
F Score	6
FCF	EUR 48.4M
FCF EV Yield	11.29x
Financing CF	-113,488,735
Fiscal Year End	June
Founded	1,976
Goodwill	157,457,393
Graham Number	35.3131
Graham Upside	33.01
Income Tax	EUR 3.4M
Investing CF	17,662,062
Is Primary Listing	0
Last Earnings Date	2026-03-18
Last Report Date	2025-12-31
Lynch Fair Value	EUR 78.24
Lynch Upside	194.7
Ma150	24.86
Ma150ch	6.8%
Ma20	25.1
Ma20ch	5.79%
Net CF	3,112,627
Next Earnings Date	2026-10-21
Open	26.55
P FCF Ratio	3.53
P OCF Ratio	1.73
Ppne	160,039,512.5
Price Date	2026-05-07
Price EBITDA	EUR 2.26
Relative Volume	6.83x
Revenue	445,314,088x
Tax By Revenue	0.77x
Tax Rate	27.48%
Tr6m	10.63%
Volume	900
Z Score	1.67

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0IP1 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0IP1 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0IP1?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.1%

Share of float held by funds and institutions

Insider ownership

+1.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.9%

Negative means the company is buying back shares.

Technical

LON/0IP1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.0

Neutral momentum band

Price vs 200-day MA

+1.3%

50/200-day relationship not available

Beta (5Y)

0.89

Moves roughly with the market

Sharpe ratio

0.33

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0IP1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0IP1 stock rating?

lon/0IP1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0IP1 analysis?

The full report lives at /stocks/lon/0IP1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0IP1?

The latest report frames lon/0IP1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0IP1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.